Dr. Prashant Kesharwani is an Assistant Professor of Pharmaceutics at Dr. Harisingh Gour Vishwavidyalaya (A Central University), Sagar, India. His work focuses on translational nanomedicine, polymeric biomaterials, targeted drug delivery, nanoengineered drug delivery systems, and translational pharmaceutical research. He has contributed extensively to the scientific literature and has served as an editor of scholarly books. Dr. Kesharwani has received research funding from national agencies and has been recognized with awards and fellowships for his contributions to the field. His research interests include nanomedicine, targeted and stimuli-responsive drug delivery, polymeric nanocarriers, and related pharmaceutical applications. He is actively involved in scientific research, academic mentoring, and scholarly publishing.

• Part 1: Phytoconstituents and Nano-phytoconstituents: Development1. Introduction to phytoconstituents2. History and development of phytoconstituents3. Phytochemicals as a leading therapeutic candidate4. Molecular targets and mechanisms of phytochemicals5. Nanotechnology for delivery of phytochemicals6. Green synthesis approach for nano-phytochemicals development7. Challenges and limitations of phytochemicals as therapeutic agentsPart 2: Phytoconstituents and Nano-phytoconstituents: Therapeutic Applications8. Development of nanocarriers to improve the delivery of phytoconstituents9. Phytochemicals-based nanoparticles in diabetes10. Phytochemicals in neurological disorders11. Nano-phytoconstituents for neurological disorders12. Phytochemicals in COVID-19 and other viral diseases13. Nano-phytochemicals in COVID-19 and other viral diseases14. Phytochemicals and nano-phytochemicals in curing rheumatoid arthritis15.Phyto constituent-based nano-carriers for treatment of acne and psoriasis16. Nano-based phytochemicals for management of burn wound healing17. Phytochemicals as an effective strategy for chemoprevention and control18. Phytochemicals for cancer therapy19. Phytochemicals-based metallic nanoparticles in cancer therapy20. Phytochemicals-based polymeric nanoparticles in cancer therapy21. Lipid-based nanocarriers for phytocompound-mediated cancer therapyPart 3: Recent advances, regulatory aspects, and future perspectives of nanophytoconstituents22. Nanomedicine for codelivery of phytochemicals in cancer treatment23. Nanotechnology for targeted delivery of bioactive phytoconstituents24. Nanomedicine for delivery of phytochemicals utilizing organic platforms25. Challenges in development of nano-phytochemicals26. Recent advances, regulatory aspects, challenges and future perspectives of nanophytoconstituents